Design and development of benzyl piperazine linked 5-phenyl-1, 2, 4-triazole-3-thione conjugates as potential agents to combat Alzheimer's disease

PVR Kiran, DK Waiker, A Verma, P Saraf… - Bioorganic …, 2023 - Elsevier
Our present work demonstrates the molecular hybridization-assisted design, synthesis, and
biological evaluation of 22 benzylpiperazine-linked 1, 2, 4-triazole compounds (PD1-22) as …

[HTML][HTML] Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer's disease

U Azam, MM Naseer, C Rochais - European Journal of Medicinal Chemistry, 2025 - Elsevier
Alzheimer's disease (AD) remains a significant healthcare challenge, necessitating
innovative therapeutic approaches to address its complex and multifactorial nature …

Selenization of Small Molecule Drugs: A New Player on the Board

C Morán-Serradilla, D Plano, C Sanmartín… - Journal of Medicinal …, 2024 - ACS Publications
There is an urgent need to develop safer and more effective modalities for the treatment of a
wide range of pathologies due to the increasing rates of drug resistance, undesired side …

Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy

A Verma, DK Waiker, N Singh, A Roy… - ACS Chemical …, 2024 - ACS Publications
An efficient and promising method of treating complex neurodegenerative diseases like
Alzheimer's disease (AD) is the multitarget-directed approach. Here in this work, a series of …

Design, synthesis, and evaluation of benzhydrylpiperazine-based novel dual COX-2/5-LOX inhibitors with anti-inflammatory and anti-cancer activity

P Saraf, B Bhardwaj, A Verma, MA Siddiqui… - RSC Medicinal …, 2025 - pubs.rsc.org
Piperazine derivatives were screened using the ChEMBL database, paving the way for the
design, synthesis, and evaluation of a novel series of dual COX-2/5-LOX inhibitors and …

Synthesis, antimicrobial evaluation, and molecular docking studies of Mannich base analogs derived from 2,3-dihydro-1,3,4-oxadiazole-2(3H)-thione scaffold

AC Mishra, J Upadhyay, PP Dixit, K Baheti, SN Thore - Chemical Papers, 2024 - Springer
A series of novel trans-3-substituted aminomethyl-5-(4-(4-chlorophenyl) cyclohexyl)-1, 3, 4-
oxadiazole-2 (3 H)-thiones was synthesized successfully from achiral trans-4-(4 …

Exploring the effect of substituents on the supramolecular assemblies built by non-covalent interactions in three closely related 1, 3, 4-oxadiazole-2 (3H)-thione …

LH Al-Wahaibi, V Krishnan, HM Hassan… - Journal of Molecular …, 2024 - Elsevier
Abstract Three closely related 1, 3, 4-oxadiazole-2 (3H)-thione N-Mannich bases were
synthesized and characterized by spectroscopic and single crystal X-ray diffraction methods …

Design, synthesis, and biological evaluation of some 2-(3-oxo-5, 6-diphenyl-1, 2, 4-triazin-2 (3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease …

DK Waiker, A Verma, TA Gajendra, A Roy… - European Journal of …, 2024 - Elsevier
Inspite of established symptomatic relief drug targets, a multi targeting approach is highly in
demand to cure Alzheimer's disease (AD). Simultaneous inhibition of cholinesterase (ChE) …

Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates …

A Singh, A Verma, B Bhardwaj, P Saraf, H Kumar… - ACS …, 2024 - ACS Publications
Alzheimer's disease (AD) is a multifactorial and emerging neurological disorder, which has
invoked researchers to develop multitargeted ligands. Herein, hybrid conjugates of 5-phenyl …

Design, synthesis and biological evaluation of novel pyrazolinone derivatives as multifunctional ligands for the treatment of Alzheimer's disease

H Wang, Y Wu, A Liu, S Li, P Zhu, J Zuo, Y Kuang… - Bioorganic …, 2025 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the
depletion of cholinergic neurons and the accumulation of amyloid β (Aβ) plaques. The …